P2 is to assess safety and efficacy, compared to a placebo. Genoa's P2 trial was started a year ahead but at a 55% reduction of viral shedding, it can only ever aspire to be therapeutic vaccine, not curative as Frazer's approach. So hopefully we will see a significantly lower % of viral shedding than Genoa's results
Flood of Foreign Cash Headed Into Small Cap Stocks, page-12
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$10.44 |
Change
-0.460(4.22%) |
Mkt cap ! $230.4M | |||
| Open | High | Low | Value | Volume |
| $10.50 | $10.50 | $10.02 | $124.7K | 11.92K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 2229 | $10.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $10.30 | 3731 | 1 |
View Market Depth
| Last trade - 10.00am 06/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |